WORK Medical Technology Group Ltd (WOK) Stock Analysis
Verdict: AVOID
Terminal decline in revenue and extreme share price erosion indicate a broken IPO model with high risk of delisting or total loss.
Investment score: 18/100
Analysis as of
Is WORK Medical Technology Group Ltd stock worth reviewing? The TradeMates thesis
WORK Medical (WOK) is a micro-cap Chinese medical supplier exhibiting classic signs of post-IPO destruction. Fundamentals are deteriorating rapidly (revenue -14% YoY), and technicals show a 94.7% 90-day loss. The model identifies this as a 'value trap' with extreme delisting risk.
7-factor investment score
- Valuation: 35/100 (weight 20%)
- Financial Health: 15/100 (weight 15%)
- Technical Momentum: 5/100 (weight 15%)
- Earnings Quality: 10/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 0/100 (weight 10%)
- Risk-Adjusted Return: 10/100 (weight 15%)
WORK Medical Technology Group Ltd opportunities and risks
What speaks for WOK
- Asset Play Potential
What speaks against WOK
- Delisting Risk
Peers and competitors
- 301234.SZ
- 688193.SS
- 2170.HK
- 2393.HK
- 300832.SZ
Frequently asked questions about WORK Medical Technology Group Ltd (WOK)
Is WOK stock a good investment?
The TradeMates model rates WORK Medical Technology Group Ltd as AVOID with an investment score of 18/100. WORK Medical (WOK) is a micro-cap Chinese medical supplier exhibiting classic signs of post-IPO destruction. Fundamentals are deteriorating rapidly (revenue -14% YoY), and technicals show a 94.7% 90-day loss. The model identifies this as a 'value trap' with extreme delisting risk. This is algorithmic model output, not personal investment advice.
Is WOK stock a buy?
The TradeMates model verdict for WOK is AVOID with an investment score of 18/100. Treat this as a model signal to review, not a personal buy recommendation.